SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 117 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $544 | -30.5% | 37,433 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $783 | -1.0% | 37,433 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $791 | -23.7% | 37,433 | -8.1% | 0.01% | -27.3% |
| Q4 2022 | $1,037 | -99.9% | 40,734 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $979,000 | -2.9% | 40,734 | -29.8% | 0.01% | +10.0% |
| Q1 2022 | $1,008,000 | -9.0% | 57,994 | +14.6% | 0.01% | 0.0% |
| Q4 2021 | $1,108,000 | +14.6% | 50,610 | 0.0% | 0.01% | +11.1% |
| Q3 2021 | $967,000 | +29.1% | 50,610 | +16.0% | 0.01% | +28.6% |
| Q2 2021 | $749,000 | -23.2% | 43,618 | 0.0% | 0.01% | -30.0% |
| Q1 2021 | $975,000 | +119.6% | 43,618 | +118.6% | 0.01% | +150.0% |
| Q4 2020 | $444,000 | – | 19,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |